These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2521445)

  • 1. Predictive genetic testing to control coronary heart disease and hyperlipidemia.
    Berg K
    Arteriosclerosis; 1989; 9(1 Suppl):I50-8. PubMed ID: 2521445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of medical genetics on research and practices in the area of cardiovascular disease.
    Berg K
    Clin Genet; 1989 Nov; 36(5):299-312. PubMed ID: 2532083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of the hyperlipidemias and coronary artery disease.
    Berg K
    Prog Clin Biol Res; 1982; 103 Pt B():111-25. PubMed ID: 7163216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetics and coronary heart disease].
    Berg K
    Tidsskr Nor Laegeforen; 1989 Oct; 109(29):3010-4. PubMed ID: 2588230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic variation in the apolipoprotein B gene].
    Vedie B; Myara I; Jeunemaitre X; Moatti N
    Ann Genet; 1995; 38(4):187-201. PubMed ID: 8629806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic research in coronary heart disease.
    Motulsky AG
    Prog Clin Biol Res; 1984; 147():541-8. PubMed ID: 6330756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery disease, lipid disorders and genetic polymorphisms.
    Ordovas JM; Schaefer EJ
    Ann Biol Clin (Paris); 1988; 46(1):24-9. PubMed ID: 2898907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of coronary heart disease and its risk factors.
    Berg K
    Ciba Found Symp; 1987; 130():14-33. PubMed ID: 2964999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease.
    Akanji AO; Suresh CG; Fatania HR; Al-Radwan R; Zubaid M
    Metabolism; 2007 Apr; 56(4):484-90. PubMed ID: 17379005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein(a)--atherogenic waste product of evolution?].
    Kronenberg F; Utermann G
    Wien Med Wochenschr; 1994; 144(12-13):324-30. PubMed ID: 8650938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein genes and hyperlipidemia.
    Baralle FE; Shoulders CC
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1351-8. PubMed ID: 6494870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twin studies of coronary heart disease and its risk factors.
    Berg K
    Acta Genet Med Gemellol (Roma); 1987; 36(4):439-53. PubMed ID: 2970198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic lipoprotein subprofiling.
    Ellington AA; Kullo IJ
    Adv Clin Chem; 2008; 46():295-317. PubMed ID: 19004193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
    Peros E; Geroldi D; D'Angelo A; Falcone C; Montagna L; Carabela M; Emanuele E
    Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.